<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Matlik K</submitter><funding>Cure Huntington’s Disease Initiative</funding><funding>Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada</funding><funding>NIA NIH HHS</funding><funding>Sigrid Juséliuksen Säätiö</funding><funding>Hereditary Disease Foundation</funding><funding>Gouvernement du Canada | Canadian Institutes of Health Research</funding><pagination>383-394</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10937393</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>56(3)</volume><pubmed_abstract>Brain region-specific degeneration and somatic expansions of the mutant Huntingtin (mHTT) CAG tract are key features of Huntington's disease (HD). However, the relationships among CAG expansions, death of specific cell types and molecular events associated with these processes are not established. Here, we used fluorescence-activated nuclear sorting (FANS) and deep molecular profiling to gain insight into the properties of cell types of the human striatum and cerebellum in HD and control donors. CAG expansions arise at mHTT in striatal medium spiny neurons (MSNs), cholinergic interneurons and cerebellar Purkinje neurons, and at mutant ATXN3 in MSNs from SCA3 donors. CAG expansions in MSNs are associated with higher levels of MSH2 and MSH3 (forming MutSβ), which can inhibit nucleolytic exci</pubmed_abstract><journal>Nature genetics</journal><pubmed_title>Cell-type-specific CAG repeat expansions and toxicity of mutant Huntingtin in human striatum and cerebellum.</pubmed_title><pmcid>PMC10937393</pmcid><funding_grant_id>P30 AG072931</funding_grant_id><funding_grant_id>P30 AG066462</funding_grant_id><funding_grant_id>U19 AG066567</funding_grant_id><funding_grant_id>P30 AG053760</funding_grant_id><funding_grant_id>FRN-388879</funding_grant_id><funding_grant_id>RGPIN-2016-06355/498835</funding_grant_id><funding_grant_id>P30 AG066509</funding_grant_id><pubmed_authors>Caron MC</pubmed_authors><pubmed_authors>Pearson CE</pubmed_authors><pubmed_authors>Kus L</pubmed_authors><pubmed_authors>Deshmukh AL</pubmed_authors><pubmed_authors>Matlik K</pubmed_authors><pubmed_authors>Paul MR</pubmed_authors><pubmed_authors>Baffuto M</pubmed_authors><pubmed_authors>Masson JY</pubmed_authors><pubmed_authors>Heintz N</pubmed_authors><pubmed_authors>Davis DA</pubmed_authors><pubmed_authors>Carroll TS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Cell-type-specific CAG repeat expansions and toxicity of mutant Huntingtin in human striatum and cerebellum.</name><description>Brain region-specific degeneration and somatic expansions of the mutant Huntingtin (mHTT) CAG tract are key features of Huntington's disease (HD). However, the relationships among CAG expansions, death of specific cell types and molecular events associated with these processes are not established. Here, we used fluorescence-activated nuclear sorting (FANS) and deep molecular profiling to gain insight into the properties of cell types of the human striatum and cerebellum in HD and control donors. CAG expansions arise at mHTT in striatal medium spiny neurons (MSNs), cholinergic interneurons and cerebellar Purkinje neurons, and at mutant ATXN3 in MSNs from SCA3 donors. CAG expansions in MSNs are associated with higher levels of MSH2 and MSH3 (forming MutSβ), which can inhibit nucleolytic exci</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2026-07-15T13:51:33.414Z</modification><creation>2026-07-05T03:11:27.634Z</creation></dates><accession>S-EPMC10937393</accession><cross_references><pubmed>38291334</pubmed><doi>10.1038/s41588-024-01653-6</doi></cross_references></HashMap>